Skip to main content
Veterinary Medicines

Urilin 40 mg/ml syrup for dogs

Not authorised
  • Phenylpropanolamine hydrochloride

Product identification

Medicine name:
Urilin 40 mg/ml syrup for dogs
Urilin 40 mg/ml sirup pre psov
Active substance:
  • Phenylpropanolamine hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Phenylpropanolamine hydrochloride
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Syrup
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG04BX91
Authorisation status:
  • Surrendered
Authorised in:
  • Slovakia
Package description:
  • 50 ml amber type III glass bottle containing 45 ml of syrup,with a low density polyethylene dropper and a polypropylene child resistant screw cap.
  • 100 ml amber type III glass bottle containing 100 ml of syrup,with a low density polyethylene dropper and a polypropylene child resistant screw cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dales Pharmaceuticals Limited
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/037/MR/10-S
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0510/001

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 8/02/2022

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."